WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported increased media attention in 2017 on the company's Quell ® Wearable Pain Relief Technology™. An Inside Look at the Latest Health Tech - The Dr. Oz Show 3 Amazing New Gadgets to Relieve Aches & Pains - Fox News Could this
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell ® will be available in over 450 Best Buy ® stores nationwide beginning in mid-February and is now available for purchase on BestBuy.com . "More and more consumers are proactively looking for technology to
2016 revenue $12.0M up 65% year-on-year; Q4 revenue $3.7M up 36% Quell device shipments of 14.3K and electrode reorders of 20K represent new quarterly highs WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW), today reported financial and business highlights for the quarter
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it plans to issue its 2016 full year and fourth quarter financial results before the opening of the market on January 26, 2017 . The Company will host a conference call at 8:00 a.m., Eastern Time on
Invoiced Value of Quell Shipments Up 19% Over Q3 2016 WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO, NUROW) reported Q4 2016 demand highlights for its Quell ® Wearable Pain Relief Technology™. During Q4 2016 the invoiced value of Quell shipments totaled
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (NASDAQ:NURO, NUROW) today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Digital Medicine Showcase 2017 at the Parc 55 San Francisco in San Francisco, CA. The Digital Medicine
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. ( NASDAQ : NURO, NUROW) announced that it has closed its previously announced private placement to a healthcare dedicated institutional investor of 7,000 shares of Series E convertible preferred stock at a price of $1,000 per share, and warrants
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO, NUROW) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the Biotech Showcase 2017 Conference being held at the Hilton San Francisco Union Square in San Francisco,
Company unveils advanced product features for Quell Wearable Pain Relief Technology at CES 2017, booth #43421 LAS VEGAS --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq:NURO, NUROW) today announced plans to unveil important advances to its Quell® Wearable Pain Relief Technology™ at CES 2017 (CES
Will not complete previously announced registered offering WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. ( NASDAQ : NURO, NUROW) announced today that it has entered into a definitive securities purchase agreement with a healthcare dedicated institutional investor in connection with a
